Guardant Health
GH
#3106
Rank
HK$30.40 B
Marketcap
HK$246.08
Share price
1.73%
Change (1 day)
15.42%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): -HK$38.48

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -HK$38.15. In 2022 the company made an earnings per share (EPS) of -HK$49.73 a decrease over its 2021 EPS that were of -HK$31.08.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$38.48-22.61%
2022-HK$49.7360%
2021-HK$31.0855.04%
2020-HK$20.05207.14%
2019-HK$6.53-19.81%
2018-HK$8.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$37.45-1.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.93-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA